Afya is trading at $13.15, up 7.61%, amid merger developments that are a plausible company-specific catalyst; reports do not explicitly link them to the pre-market gain.
- Afya’s planned merger with YDUQS, announced September 23, would combine the companies; Afya shareholders are set to own 69% of the combined group. The transaction remains subject to approvals.
- A voting commitment agreement involving controlling shareholders was also reported ahead of this session. No volume information was provided.